|
AI Limit for Nitroso Nebivolol
|
|
11
|
1867
|
April 3, 2024
|
|
MEGLUMINE (Methylglucamine)
|
|
15
|
1739
|
March 12, 2024
|
|
Discussion on Cleaning Validation Requirements for Nitrosamines
|
|
2
|
303
|
February 14, 2024
|
|
N- nitroso Nitazoxanide
|
|
1
|
236
|
February 8, 2024
|
|
Nitrosamine Impurities in Topical Drug Product
|
|
3
|
404
|
February 3, 2024
|
|
10º encontro Farmacopeia Brasileira
|
|
0
|
372
|
November 30, 2023
|
|
Risk analysis of nitrosamine impurities in liquid products (essences and flavors)
|
|
2
|
360
|
November 14, 2023
|
|
Nitrosamines risk assessments for Topical herbal extracts
|
|
1
|
375
|
September 20, 2023
|
|
Apixaban Drug Substance-Related Impurities (NDSRIs)
|
|
3
|
955
|
September 15, 2023
|
|
Total impurities limit if more than one nitrosamine impurities are observed in product
|
|
4
|
508
|
August 14, 2023
|
|
The Nitrosamine “Saga”
|
|
3
|
1430
|
July 29, 2023
|
|
FDA Workshop: Mitigation Strategies for Nitrosamine Drug Substance Related Impurities
|
|
11
|
2690
|
July 27, 2023
|
|
NDSRIs: Atualizações e Desafios
|
|
0
|
370
|
July 24, 2023
|
|
N-nitroso Des-methyl Dapoxetine
|
|
12
|
935
|
May 31, 2023
|
|
Setting limit for Nitrite and Nitrate in water used for Active Ingredients synthesis
|
|
2
|
922
|
May 23, 2023
|
|
Carry over limits for Niitrsoamines
|
|
2
|
578
|
February 12, 2023
|
|
Nitrosamine risks that may arise from the filters
|
|
2
|
635
|
January 4, 2023
|
|
Cleaning Validations Criteria
|
|
1
|
1208
|
December 5, 2022
|
|
2 days seminar on nitrosamine and extractable & leachable
|
|
0
|
449
|
November 21, 2022
|
|
Nitrite / Nitrosamine levels in Excipients
|
|
0
|
432
|
November 17, 2022
|
|
Azithromycin - presence of N-Nitrosamines
|
|
8
|
710
|
March 3, 2022
|
|
Mutagenic Impurities Strategies for Identification and Control - now published
|
|
9
|
404
|
March 2, 2022
|